What are cookies?

Our site uses cookies. A cookie is a small text marker stored on your computer that enables us to track the use of our website. We use cookies to help us understand what our users' interests and preferences are to ensure the website is as user friendly as possible.

This site only uses cookies in order to provide a service to visitors. No personal data is stored in cookies and cookies are not used in order to provide advertising. Cookies are used for the following purposes:

Learn more about cookies on aboutcookies.org

If you have any concerns about the processing of your personal data by the Dementia Action Alliance, please contact the Secretariat, c/o Alzheimer's Society, 43-44 Crutched Friars, London, EC3N 2AE.

Accept and continue

Re:Cognition Health

Re:Cognition Health provides a comprehensive and innovative clinical approach to the diagnosis and treatment of all types of cognitive impairment. We are also an International Clinical Trials Site for Alzheimer's and other dementias. We participate in the final stages of a growing number of global clinical trials for ground-breaking disease modifying medications.

10 February 2016
Care, Medical, Pharmaceutical, Health

1. Action Plan

1. The National Dementia Declaration lists seven outcomes that the DAA are seeking to achieve for people with dementia and their carers. How would you describe your organisation’s role in delivering better outcomes for people with dementia and their carers?

As an International Clinical Trials site, our role is to help give hope to those diagnosed with dementia and their carers. Taking part in a trial can bring significant benefits to people with a diagnosis. They are able to access new medicines often years in advance of them being made publicly available. They also get an incredible level of free healthcare and support not available elsewhere. This provides comfort, continuity and a sense of community for all those involved.

2. What are the challenges to delivering these outcomes from the perspective of your organisation?

There is very little public awareness of the significant benefits of clinical trials for Alzheimer's and other dementias. This is despite a recent directive from the Government's Chief Medical Office Professor Dame Sally Davies to all NHS Trusts and all other healthcare organisations that everyone who have the opportunity of doing so enter a trial. Our biggest challenge is to make everyone aware of the opportunity.

2. Actions

  • Availability and accessibility

    Increase the availability and accessibility of early diagnosis and clinical trial centres by opening new sites.


    2014 - Third Quarter Update

    Good progress being made on opening new clinical trials site in Guildford clinic.

  • Increasing awareness of the benefits of clinical trials

    Advertising and marketing.

    Providing free public speaking forums. 


    2014 - Third Quarter Update

    Variety of newspaper and magazine advertising with editorial copy.

    5 public forums delivered.

  • Participate in a growing number of clinical trials to help a wider range of diagnoses

    Seek to secure the appointment to a growing number of global clinical trials for the benefit of the UK population.

    Being implemented